A phase II trial of the pan-HER inhibitor poziotinib, in patients with HER2-positive metastatic breast cancer who had received at least two prior HER2-directed regimens: results of the NOV120101-203 trial
| Image |  |
|---|---|
| Description | scientific article published on 07 November 2018 |
| Author/s |
author: Seock-Ah Im Yeon Hee Park |
| Publication date | November 7, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |